nodes	percent_of_prediction	percent_of_DWPC	metapath
Niflumic Acid—CLCNKA—hypertension	0.535	0.896	CbGaD
Niflumic Acid—PTGS1—Minoxidil—hypertension	0.047	0.227	CbGbCtD
Niflumic Acid—PTGS1—Torasemide—hypertension	0.043	0.208	CbGbCtD
Niflumic Acid—PTGS1—Candesartan—hypertension	0.0399	0.193	CbGbCtD
Niflumic Acid—PTGS1—hypertension	0.0396	0.0663	CbGaD
Niflumic Acid—PTGS2—Bumetanide—hypertension	0.0298	0.144	CbGbCtD
Niflumic Acid—PTGS1—Irbesartan—hypertension	0.0247	0.119	CbGbCtD
Niflumic Acid—PTGS2—hypertension	0.0226	0.0379	CbGaD
Niflumic Acid—CLCNKA—collecting duct of renal tubule—hypertension	0.0226	0.312	CbGeAlD
Niflumic Acid—PTGS1—Carvedilol—hypertension	0.0222	0.108	CbGbCtD
Niflumic Acid—CLCNKA—nephron—hypertension	0.01	0.139	CbGeAlD
Niflumic Acid—PLA2G1B—nephron—hypertension	0.00397	0.0548	CbGeAlD
Niflumic Acid—Ridogrel—TBXAS1—hypertension	0.00249	0.583	CrCbGaD
Niflumic Acid—CLCNKA—nephron tubule—hypertension	0.00217	0.0299	CbGeAlD
Niflumic Acid—CLCNKA—kidney—hypertension	0.00191	0.0263	CbGeAlD
Niflumic Acid—PLA2G1B—blood vessel—hypertension	0.00173	0.0238	CbGeAlD
Niflumic Acid—Leflunomide—AHR—hypertension	0.00111	0.26	CrCbGaD
Niflumic Acid—SLC16A7—cardiac ventricle—hypertension	0.00105	0.0144	CbGeAlD
Niflumic Acid—SLC16A7—myocardium—hypertension	0.000985	0.0136	CbGeAlD
Niflumic Acid—PTGS2—nephron—hypertension	0.000913	0.0126	CbGeAlD
Niflumic Acid—PTGS2—hindlimb—hypertension	0.000831	0.0115	CbGeAlD
Niflumic Acid—PLA2G1B—heart—hypertension	0.000816	0.0113	CbGeAlD
Niflumic Acid—PLA2G1B—cardiovascular system—hypertension	0.00077	0.0106	CbGeAlD
Niflumic Acid—PLA2G1B—kidney—hypertension	0.000753	0.0104	CbGeAlD
Niflumic Acid—SLC16A7—nephron tubule—hypertension	0.000722	0.00997	CbGeAlD
Niflumic Acid—SLC16A7—adrenal cortex—hypertension	0.000711	0.00981	CbGeAlD
Niflumic Acid—UGT1A9—kidney—hypertension	0.000689	0.00951	CbGeAlD
Niflumic Acid—SLC16A7—heart—hypertension	0.000687	0.00949	CbGeAlD
Niflumic Acid—SLC16A7—decidua—hypertension	0.000668	0.00923	CbGeAlD
Niflumic Acid—SLC16A1—cardiac ventricle—hypertension	0.000666	0.0092	CbGeAlD
Niflumic Acid—SLC16A7—cardiovascular system—hypertension	0.000648	0.00895	CbGeAlD
Niflumic Acid—SLC16A1—myocardium—hypertension	0.000627	0.00865	CbGeAlD
Niflumic Acid—SLC16A7—cortex of kidney—hypertension	0.000618	0.00853	CbGeAlD
Niflumic Acid—PLA2G1B—adrenal gland—hypertension	0.000609	0.00841	CbGeAlD
Niflumic Acid—SLC16A7—cardiac atrium—hypertension	0.000588	0.00811	CbGeAlD
Niflumic Acid—SLC16A7—medulla oblongata—hypertension	0.000554	0.00765	CbGeAlD
Niflumic Acid—PTGS1—artery—hypertension	0.000533	0.00735	CbGeAlD
Niflumic Acid—PLA2G1B—endocrine gland—hypertension	0.000528	0.00729	CbGeAlD
Niflumic Acid—PLA2G4A—adrenal cortex—hypertension	0.000514	0.00709	CbGeAlD
Niflumic Acid—SLC16A7—adrenal gland—hypertension	0.000513	0.00708	CbGeAlD
Niflumic Acid—PTGS2—artery—hypertension	0.000509	0.00703	CbGeAlD
Niflumic Acid—PLA2G4A—heart—hypertension	0.000497	0.00686	CbGeAlD
Niflumic Acid—PLA2G4A—smooth muscle tissue—hypertension	0.000493	0.0068	CbGeAlD
Niflumic Acid—PLA2G4A—decidua—hypertension	0.000483	0.00667	CbGeAlD
Niflumic Acid—UGT1A9—endocrine gland—hypertension	0.000483	0.00667	CbGeAlD
Niflumic Acid—PLA2G1B—central nervous system—hypertension	0.000476	0.00657	CbGeAlD
Niflumic Acid—PLA2G4A—cardiovascular system—hypertension	0.000469	0.00647	CbGeAlD
Niflumic Acid—PTGS1—endothelium—hypertension	0.00045	0.00621	CbGeAlD
Niflumic Acid—PLA2G4A—cortex of kidney—hypertension	0.000447	0.00617	CbGeAlD
Niflumic Acid—SLC16A7—endocrine gland—hypertension	0.000445	0.00614	CbGeAlD
Niflumic Acid—SLC16A1—heart—hypertension	0.000437	0.00604	CbGeAlD
Niflumic Acid—PTGS2—endothelium—hypertension	0.00043	0.00594	CbGeAlD
Niflumic Acid—SLC16A1—decidua—hypertension	0.000425	0.00587	CbGeAlD
Niflumic Acid—PTGS1—blood vessel—hypertension	0.000415	0.00573	CbGeAlD
Niflumic Acid—PLA2G4A—Enalapril—Captopril—hypertension	0.000415	0.144	CbGdCrCtD
Niflumic Acid—SLC16A1—cardiovascular system—hypertension	0.000413	0.0057	CbGeAlD
Niflumic Acid—SLC16A1—kidney—hypertension	0.000404	0.00558	CbGeAlD
Niflumic Acid—SLC16A7—central nervous system—hypertension	0.000401	0.00553	CbGeAlD
Niflumic Acid—PLA2G4A—medulla oblongata—hypertension	0.000401	0.00553	CbGeAlD
Niflumic Acid—PTGS2—blood vessel—hypertension	0.000397	0.00548	CbGeAlD
Niflumic Acid—SLC16A1—cardiac atrium—hypertension	0.000374	0.00516	CbGeAlD
Niflumic Acid—PLA2G4A—adrenal gland—hypertension	0.000371	0.00512	CbGeAlD
Niflumic Acid—SLC16A1—medulla oblongata—hypertension	0.000353	0.00487	CbGeAlD
Niflumic Acid—SLC16A1—adrenal gland—hypertension	0.000327	0.00451	CbGeAlD
Niflumic Acid—PLA2G4A—endocrine gland—hypertension	0.000322	0.00444	CbGeAlD
Niflumic Acid—Floctafenine—PTGS1—hypertension	0.000308	0.0719	CrCbGaD
Niflumic Acid—PLA2G4A—Enalapril—Fosinopril—hypertension	0.000296	0.102	CbGdCrCtD
Niflumic Acid—PLA2G4A—central nervous system—hypertension	0.00029	0.004	CbGeAlD
Niflumic Acid—SLC16A1—endocrine gland—hypertension	0.000283	0.00391	CbGeAlD
Niflumic Acid—PTGS1—myocardium—hypertension	0.000281	0.00388	CbGeAlD
Niflumic Acid—PLA2G4A—Enalapril—Moexipril—hypertension	0.000256	0.0887	CbGdCrCtD
Niflumic Acid—SLC16A1—central nervous system—hypertension	0.000255	0.00352	CbGeAlD
Niflumic Acid—PLA2G4A—Enalapril—Perindopril—hypertension	0.000224	0.0775	CbGdCrCtD
Niflumic Acid—PLA2G4A—Enalapril—Quinapril—hypertension	0.000212	0.0735	CbGdCrCtD
Niflumic Acid—PLA2G4A—Enalapril—Benazepril—hypertension	0.000207	0.0717	CbGdCrCtD
Niflumic Acid—PTGS1—heart—hypertension	0.000196	0.00271	CbGeAlD
Niflumic Acid—PTGS1—smooth muscle tissue—hypertension	0.000195	0.00269	CbGeAlD
Niflumic Acid—PTGS2—adrenal cortex—hypertension	0.000194	0.00268	CbGeAlD
Niflumic Acid—PTGS2—heart—hypertension	0.000188	0.00259	CbGeAlD
Niflumic Acid—PTGS2—smooth muscle tissue—hypertension	0.000186	0.00257	CbGeAlD
Niflumic Acid—PTGS1—cardiovascular system—hypertension	0.000185	0.00256	CbGeAlD
Niflumic Acid—PLA2G4A—Pindolol—Nadolol—hypertension	0.000183	0.0634	CbGdCrCtD
Niflumic Acid—PTGS1—kidney—hypertension	0.000181	0.0025	CbGeAlD
Niflumic Acid—PTGS2—cardiovascular system—hypertension	0.000177	0.00244	CbGeAlD
Niflumic Acid—Floctafenine—PTGS2—hypertension	0.000176	0.0411	CrCbGaD
Niflumic Acid—PLA2G4A—Enalapril—Trandolapril—hypertension	0.000175	0.0605	CbGdCrCtD
Niflumic Acid—PTGS2—kidney—hypertension	0.000173	0.00239	CbGeAlD
Niflumic Acid—PTGS1—cardiac atrium—hypertension	0.000168	0.00232	CbGeAlD
Niflumic Acid—PLA2G4A—Pindolol—Acebutolol—hypertension	0.000161	0.0558	CbGdCrCtD
Niflumic Acid—PTGS2—medulla oblongata—hypertension	0.000151	0.00209	CbGeAlD
Niflumic Acid—PTGS1—adrenal gland—hypertension	0.000146	0.00202	CbGeAlD
Niflumic Acid—PLA2G4A—Pindolol—Metoprolol—hypertension	0.000146	0.0507	CbGdCrCtD
Niflumic Acid—PTGS2—adrenal gland—hypertension	0.00014	0.00193	CbGeAlD
Niflumic Acid—PLA2G4A—Pindolol—Esmolol—hypertension	0.000139	0.048	CbGdCrCtD
Niflumic Acid—PLA2G4A—Enalapril—Lisinopril—hypertension	0.000137	0.0474	CbGdCrCtD
Niflumic Acid—PLA2G4A—Enalapril—Ramipril—hypertension	0.000133	0.0459	CbGdCrCtD
Niflumic Acid—PTGS1—endocrine gland—hypertension	0.000127	0.00175	CbGeAlD
Niflumic Acid—PLA2G4A—Pindolol—Betaxolol—hypertension	0.000122	0.0423	CbGdCrCtD
Niflumic Acid—PTGS2—endocrine gland—hypertension	0.000121	0.00168	CbGeAlD
Niflumic Acid—Mefenamic acid—PTGS1—hypertension	0.00012	0.0281	CrCbGaD
Niflumic Acid—PTGS1—central nervous system—hypertension	0.000114	0.00158	CbGeAlD
Niflumic Acid—PTGS2—central nervous system—hypertension	0.000109	0.00151	CbGeAlD
Niflumic Acid—PLA2G4A—Pindolol—Propranolol—hypertension	8.29e-05	0.0287	CbGdCrCtD
Niflumic Acid—Mefenamic acid—PTGS2—hypertension	6.86e-05	0.0161	CrCbGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—POMC—hypertension	3.91e-06	3.36e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—EDN1—hypertension	3.88e-06	3.34e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—SLC2A4—hypertension	3.88e-06	3.34e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—GCG—hypertension	3.88e-06	3.34e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—SLC9A1—hypertension	3.87e-06	3.32e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—GSTT1—hypertension	3.87e-06	3.32e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—AGT—hypertension	3.86e-06	3.32e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CCL5—hypertension	3.85e-06	3.31e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—ADRBK1—hypertension	3.84e-06	3.3e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—CETP—hypertension	3.82e-06	3.29e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—GCLC—hypertension	3.82e-06	3.29e-05	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—ALB—hypertension	3.8e-06	3.27e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—GSTM1—hypertension	3.8e-06	3.27e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—TP53—hypertension	3.8e-06	3.27e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—CALM1—hypertension	3.79e-06	3.26e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—NOS1—hypertension	3.78e-06	3.25e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—APOE—hypertension	3.78e-06	3.25e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—LPL—hypertension	3.77e-06	3.24e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—CALM2—hypertension	3.77e-06	3.24e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—GOT1—hypertension	3.76e-06	3.23e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—hypertension	3.75e-06	3.23e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—CAV1—hypertension	3.74e-06	3.22e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—H2AFX—hypertension	3.74e-06	3.22e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—RPS6KB1—hypertension	3.73e-06	3.21e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—PDGFRB—hypertension	3.73e-06	3.21e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—LPL—hypertension	3.73e-06	3.21e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—APOA1—hypertension	3.73e-06	3.21e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—ADCY5—hypertension	3.69e-06	3.17e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—SLC2A4—hypertension	3.68e-06	3.16e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—PRKCG—hypertension	3.66e-06	3.15e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—CYP17A1—hypertension	3.66e-06	3.15e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—ADCY5—hypertension	3.66e-06	3.14e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—STK11—hypertension	3.65e-06	3.14e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—CYP19A1—hypertension	3.65e-06	3.14e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—GPX1—hypertension	3.64e-06	3.13e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—ITGB3—hypertension	3.64e-06	3.13e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—PRKCA—hypertension	3.64e-06	3.13e-05	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—PIK3R1—hypertension	3.64e-06	3.13e-05	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—NOS3—hypertension	3.64e-06	3.13e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—ENO1—hypertension	3.62e-06	3.11e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—PTGS1—hypertension	3.62e-06	3.11e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—YWHAZ—hypertension	3.61e-06	3.1e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—PRKCA—hypertension	3.61e-06	3.1e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—CYP1A1—hypertension	3.61e-06	3.1e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—KL—hypertension	3.61e-06	3.1e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—NGF—hypertension	3.57e-06	3.07e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—SPP1—hypertension	3.57e-06	3.07e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—ALB—hypertension	3.56e-06	3.06e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—GOT1—hypertension	3.56e-06	3.06e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—CXCL8—hypertension	3.55e-06	3.06e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—CD36—hypertension	3.55e-06	3.05e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—PRL—hypertension	3.51e-06	3.02e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—CTGF—hypertension	3.49e-06	3e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—PRKCD—hypertension	3.47e-06	2.99e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CCR5—hypertension	3.47e-06	2.99e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—HDAC1—hypertension	3.46e-06	2.97e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—GOT2—hypertension	3.46e-06	2.97e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—HMGCR—hypertension	3.46e-06	2.97e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—PTEN—hypertension	3.42e-06	2.94e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3R1—hypertension	3.41e-06	2.93e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—HTR2A—hypertension	3.4e-06	2.92e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—C3—hypertension	3.39e-06	2.92e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—COMT—hypertension	3.39e-06	2.92e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—ADRA2A—hypertension	3.38e-06	2.91e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—MTHFR—hypertension	3.36e-06	2.89e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—GNB3—hypertension	3.34e-06	2.88e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—PPARGC1A—hypertension	3.34e-06	2.88e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—HMOX1—hypertension	3.33e-06	2.86e-05	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—PTGS2—hypertension	3.33e-06	2.86e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—PDGFB—hypertension	3.3e-06	2.84e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—PPARA—hypertension	3.3e-06	2.84e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—PPARG—hypertension	3.29e-06	2.83e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—PRKCE—hypertension	3.29e-06	2.83e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—FGFR1—hypertension	3.29e-06	2.83e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—CAT—hypertension	3.28e-06	2.82e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—EP300—hypertension	3.27e-06	2.81e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—GNAS—hypertension	3.26e-06	2.8e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—PDGFA—hypertension	3.25e-06	2.79e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—POMC—hypertension	3.25e-06	2.79e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—HIF1A—hypertension	3.24e-06	2.78e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—INS—hypertension	3.23e-06	2.78e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—AGT—hypertension	3.22e-06	2.77e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—AKT1—hypertension	3.21e-06	2.76e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—TGFBR2—hypertension	3.2e-06	2.75e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—AGT—hypertension	3.19e-06	2.75e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—APOB—hypertension	3.19e-06	2.74e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CALM1—hypertension	3.17e-06	2.73e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—TH—hypertension	3.17e-06	2.72e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—APOE—hypertension	3.16e-06	2.72e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—LEP—hypertension	3.16e-06	2.72e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—CALM2—hypertension	3.15e-06	2.71e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—CALM1—hypertension	3.14e-06	2.7e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—APOE—hypertension	3.13e-06	2.69e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CAV1—hypertension	3.13e-06	2.69e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—APOA1—hypertension	3.12e-06	2.69e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—CAV1—hypertension	3.1e-06	2.67e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—GSTM1—hypertension	3.1e-06	2.67e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—KDR—hypertension	3.09e-06	2.66e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—APOA1—hypertension	3.09e-06	2.66e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—GCG—hypertension	3.08e-06	2.65e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—SLC2A4—hypertension	3.08e-06	2.65e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—LPL—hypertension	3.04e-06	2.62e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—APOB—hypertension	3.02e-06	2.6e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—GOT1—hypertension	2.98e-06	2.56e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—ADCY5—hypertension	2.98e-06	2.56e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—PRKCB—hypertension	2.98e-06	2.56e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—FN1—hypertension	2.98e-06	2.56e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—F2—hypertension	2.98e-06	2.56e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—GPX1—hypertension	2.97e-06	2.55e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—ALB—hypertension	2.96e-06	2.54e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—PRKCA—hypertension	2.94e-06	2.53e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—CYP1A1—hypertension	2.94e-06	2.53e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—NOTCH1—hypertension	2.92e-06	2.51e-05	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—PTEN—hypertension	2.9e-06	2.5e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—STK11—hypertension	2.9e-06	2.49e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—CYP19A1—hypertension	2.9e-06	2.49e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—CD36—hypertension	2.89e-06	2.49e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—LPL—hypertension	2.89e-06	2.48e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—H2AFX—hypertension	2.86e-06	2.46e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—PDGFRB—hypertension	2.86e-06	2.46e-05	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—AKT1—hypertension	2.86e-06	2.46e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—NOS3—hypertension	2.83e-06	2.43e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—PIK3R1—hypertension	2.83e-06	2.43e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—ADCY5—hypertension	2.83e-06	2.43e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—PRKCG—hypertension	2.81e-06	2.41e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—PRKCA—hypertension	2.79e-06	2.4e-05	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—EP300—hypertension	2.77e-06	2.38e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—YWHAZ—hypertension	2.76e-06	2.38e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—MTHFR—hypertension	2.74e-06	2.36e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—PPARG—hypertension	2.73e-06	2.34e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—PTEN—hypertension	2.72e-06	2.34e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—POMC—hypertension	2.71e-06	2.33e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—INS—hypertension	2.7e-06	2.32e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—COMT—hypertension	2.69e-06	2.31e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—PPARA—hypertension	2.69e-06	2.31e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—POMC—hypertension	2.69e-06	2.31e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—INS—hypertension	2.67e-06	2.3e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—PRKCD—hypertension	2.66e-06	2.29e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—CCR5—hypertension	2.66e-06	2.29e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CCL2—hypertension	2.66e-06	2.28e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—GNB3—hypertension	2.65e-06	2.28e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—PPARGC1A—hypertension	2.65e-06	2.28e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—HMOX1—hypertension	2.64e-06	2.27e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—IGF1—hypertension	2.61e-06	2.24e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—AKT2—hypertension	2.61e-06	2.24e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—CAT—hypertension	2.61e-06	2.24e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—AGT—hypertension	2.6e-06	2.24e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—MTHFR—hypertension	2.6e-06	2.23e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—EGFR—hypertension	2.6e-06	2.23e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—EP300—hypertension	2.59e-06	2.23e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—PTGS2—hypertension	2.59e-06	2.23e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—GNAS—hypertension	2.58e-06	2.22e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—CALM1—hypertension	2.56e-06	2.2e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—APOE—hypertension	2.55e-06	2.19e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—APOB—hypertension	2.53e-06	2.18e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—PDGFB—hypertension	2.53e-06	2.17e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—CAV1—hypertension	2.53e-06	2.17e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—APOA1—hypertension	2.52e-06	2.17e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—FGFR1—hypertension	2.52e-06	2.16e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—SERPINE1—hypertension	2.48e-06	2.13e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—HIF1A—hypertension	2.48e-06	2.13e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—GSTM1—hypertension	2.46e-06	2.12e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—ALB—hypertension	2.45e-06	2.11e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—CALM1—hypertension	2.43e-06	2.09e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—APOE—hypertension	2.42e-06	2.08e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—LPL—hypertension	2.42e-06	2.08e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—FGF2—hypertension	2.4e-06	2.06e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—CAV1—hypertension	2.4e-06	2.06e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—RHOA—hypertension	2.39e-06	2.06e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—APOA1—hypertension	2.39e-06	2.06e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—NOS3—hypertension	2.37e-06	2.03e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—PIK3R1—hypertension	2.37e-06	2.03e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—ADCY5—hypertension	2.37e-06	2.03e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—GPX1—hypertension	2.36e-06	2.03e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—NOS3—hypertension	2.35e-06	2.02e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—PIK3R1—hypertension	2.35e-06	2.02e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—PRKCA—hypertension	2.33e-06	2.01e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—CYP1A1—hypertension	2.33e-06	2.01e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—CD36—hypertension	2.3e-06	1.97e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—PTEN—hypertension	2.26e-06	1.94e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—NOS2—hypertension	2.25e-06	1.94e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—NOTCH1—hypertension	2.23e-06	1.92e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—RELA—hypertension	2.23e-06	1.92e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—PPARG—hypertension	2.22e-06	1.91e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—POMC—hypertension	2.19e-06	1.88e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—MTOR—hypertension	2.18e-06	1.88e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—INS—hypertension	2.18e-06	1.87e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—MTHFR—hypertension	2.18e-06	1.87e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—EP300—hypertension	2.15e-06	1.85e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—PTGS2—hypertension	2.14e-06	1.84e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—PPARA—hypertension	2.13e-06	1.84e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CXCL8—hypertension	2.1e-06	1.81e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—AGT—hypertension	2.07e-06	1.78e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—INS—hypertension	2.07e-06	1.78e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—CALM1—hypertension	2.03e-06	1.75e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—APOE—hypertension	2.03e-06	1.74e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—CAV1—hypertension	2.01e-06	1.73e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—APOA1—hypertension	2e-06	1.72e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—ALB—hypertension	2e-06	1.72e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—AKT2—hypertension	2e-06	1.72e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—IL6—hypertension	2e-06	1.72e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—PIK3R1—hypertension	1.91e-06	1.64e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—NOS3—hypertension	1.91e-06	1.64e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—MMP9—hypertension	1.9e-06	1.63e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—SERPINE1—hypertension	1.9e-06	1.63e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CDKN1A—hypertension	1.89e-06	1.63e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—PTEN—hypertension	1.89e-06	1.62e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—PTEN—hypertension	1.87e-06	1.61e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—MAPK8—hypertension	1.85e-06	1.59e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—AKT1—hypertension	1.84e-06	1.58e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—FGF2—hypertension	1.84e-06	1.58e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—RHOA—hypertension	1.83e-06	1.57e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—PIK3R1—hypertension	1.81e-06	1.56e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—NOS3—hypertension	1.81e-06	1.56e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—EP300—hypertension	1.8e-06	1.55e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—EP300—hypertension	1.78e-06	1.53e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—PPARG—hypertension	1.76e-06	1.52e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—SRC—hypertension	1.75e-06	1.51e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—PTGS2—hypertension	1.75e-06	1.5e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—POMC—hypertension	1.74e-06	1.5e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—INS—hypertension	1.73e-06	1.49e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—VEGFA—hypertension	1.7e-06	1.47e-05	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—AKT1—hypertension	1.67e-06	1.44e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—MTOR—hypertension	1.67e-06	1.44e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—ALB—hypertension	1.59e-06	1.36e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—MYC—hypertension	1.57e-06	1.35e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—TGFB1—hypertension	1.56e-06	1.35e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—EGFR—hypertension	1.53e-06	1.32e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—PTEN—hypertension	1.52e-06	1.31e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—PIK3R1—hypertension	1.52e-06	1.3e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—NOS3—hypertension	1.52e-06	1.3e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—EP300—hypertension	1.45e-06	1.25e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—CDKN1A—hypertension	1.45e-06	1.25e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—PTEN—hypertension	1.45e-06	1.24e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—EP300—hypertension	1.38e-06	1.19e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—SRC—hypertension	1.34e-06	1.15e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—AKT1—hypertension	1.3e-06	1.12e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—TP53—hypertension	1.29e-06	1.11e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—PTEN—hypertension	1.21e-06	1.04e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—MYC—hypertension	1.2e-06	1.03e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—TGFB1—hypertension	1.2e-06	1.03e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—IL6—hypertension	1.18e-06	1.01e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—EGFR—hypertension	1.17e-06	1.01e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—EP300—hypertension	1.15e-06	9.93e-06	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—AKT1—hypertension	1.09e-06	9.35e-06	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—AKT1—hypertension	1.08e-06	9.27e-06	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—IL6—hypertension	9.03e-07	7.76e-06	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—AKT1—hypertension	8.79e-07	7.56e-06	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—AKT1—hypertension	8.33e-07	7.16e-06	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—AKT1—hypertension	6.98e-07	6e-06	CbGpPWpGaD
